Rosetta Genomics
 

Rosetta Genomics is the first commercial entity to focus on the emerging field of microRNA. The company is a leader in medical research and product development based on microRNA. Using our own proprietary bioinformatic technologies, researchers at Rosetta Genomics have identified the majority of human microRNA of which we are aware. From this unparalleled intellectual property platform, Rosetta is actively advancing multiple internal programs in microRNA diagnostic and therapeutic product development. We are also establishing licensing agreements and collaborative relationships with leading companies and research institutions working to develop microRNA-based products.

 

 
News & Events
 
Click icon above for latest presentation



April 28, 2008
Rosetta Genomics announces expansion of its intellectual
property estate...More

April 14, 2008
Rosetta Genomics signs agreement with west coast CLIA
certified...More



Events Calendar click here

 
 
© 2006 All rights reserved to Rosetta Genomics.
Web Building